No image available for this title

LITERATURE

ORAL SUPPLEMENTATION WITH FERROUS SULFATE BUT NOT WITH NONIONIC IRON POLYMALTOSE COMPLEX lNCREASES THE SUSCEPTIBILITY OF PLASMA LIPOPROTEINS TO OXIDATION


Iron deficiency anemia is customarily treated by iron supplementation. However, iron can act as a catalyst of lipid peroxidation in vitro, and high intake of heme iron has been associated with an increased risk of myocardial infarction in some, but not in all
epidemiologic studies. We carried out a 6-month trial of the effects of supplementation of men (n=48) with low iron stores with ferrous sulfate (180 mg of iron per day), iron polymaltose complex (200 mg of iron per day) or placebo


Availability

Feritrin-003Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Nutrition Research, Vol. 19, No. 8, pp. 1121-1132,1999
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous